DIFFERENTIALLY EXPRESSED CIRCULATING LONG-NONCODING RNAS IN PREMATURE INFANTS WITH RESPIRATORY DISTRESS SYNDROME
Bao ZD, Wan J, Zhu W, Shen JX, Yang Y, Zhou XY
*Corresponding Author: Dr. Yang Yang and Dr. Zhou Xiao‑Yu, E‑mail: yy860507@126.com (YY) and xyzhou161@163.com (XYZ), Tel:+ 86-25-83117362, Department of Neonatology, Children’s Hospital of Nanjing Medical University, Nanjing, Jiangsu 210008, P.R. China
page: 11

INTRODUCTION

Preterm respiratory distress syndrome (RDS), characterized by immature lung development, has been a severe problem for preterm infants [1]. Effective treatments include pulmonary surfactant (PS) replacement and lung-protective ventilatory strategies that could improve oxygenation and minimize ventilator-induced lung injury [2]. Recent studies have shown that normal or abnormal lung development is highly regulated by various signal molecules, including fibroblast growth factor (FGF), bone morphogenetic protein-4 (BMP‑4), transforming growth factor-beta (TGF‑β), etc. [2-3]. Long non-coding RNAs (lncRNAs) could modulate gene expression at the post-transcription level by depredating or translating target mRNAs [4]. So far, lncRNAs, characterized by a length longer than 200 nucleotides, have been demonstrated to participate in lung development and related diseases [5]. The specific expression patterns of lncRNAs have been explored in fetal lung development. Among distinct embryonic periods of lung development, a total of 687 differentially expressed lncRNAs were identified in our previous study [6]. In addition, Herriges et al. further reported that LL18/NANCI (Nkx2.1-associated noncoding intergenic RNA) and LL34 play important roles in lung development by controlling the expression of developmental transcription factors and pathways [7]. Previous studies have indicated that the components of peripheral cord blood are important clues for the identification of neonatal diseases [8]. For example, in our previous study [5 cases in neonatal acute respiratory distress syndrome (NARDS) group and 5 cases in non-NARDS group], circRNA expression profiles, in which 741 circRNAs were downregulated and 588 were upregulated, were screened with circRNA high-throughput sequencing [9]. However, the detailed molecular regulatory mechanism still remains unclear. Further exploring the role of RNAs is still important to the field of medical research. To date, few studies have investigated the role of circulating lncRNAs in RDS infants. Therefore, we planned to analyze the expression of plasma lncRNAs by RNA-sequencing and real-time quantitative PCR, then explored the potential function of differentially expressed lncRNAs by Gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) in RDS infants. This research could add more useful evidence to the further study of RDS.



Number 27
VOL. 27 (2), 2024
Number 27
VOL. 27 (1), 2024
Number 26
Number 26 VOL. 26(2), 2023 All in one
Number 26
VOL. 26(2), 2023
Number 26
VOL. 26, 2023 Supplement
Number 26
VOL. 26(1), 2023
Number 25
VOL. 25(2), 2022
Number 25
VOL. 25 (1), 2022
Number 24
VOL. 24(2), 2021
Number 24
VOL. 24(1), 2021
Number 23
VOL. 23(2), 2020
Number 22
VOL. 22(2), 2019
Number 22
VOL. 22(1), 2019
Number 22
VOL. 22, 2019 Supplement
Number 21
VOL. 21(2), 2018
Number 21
VOL. 21 (1), 2018
Number 21
VOL. 21, 2018 Supplement
Number 20
VOL. 20 (2), 2017
Number 20
VOL. 20 (1), 2017
Number 19
VOL. 19 (2), 2016
Number 19
VOL. 19 (1), 2016
Number 18
VOL. 18 (2), 2015
Number 18
VOL. 18 (1), 2015
Number 17
VOL. 17 (2), 2014
Number 17
VOL. 17 (1), 2014
Number 16
VOL. 16 (2), 2013
Number 16
VOL. 16 (1), 2013
Number 15
VOL. 15 (2), 2012
Number 15
VOL. 15, 2012 Supplement
Number 15
Vol. 15 (1), 2012
Number 14
14 - Vol. 14 (2), 2011
Number 14
The 9th Balkan Congress of Medical Genetics
Number 14
14 - Vol. 14 (1), 2011
Number 13
Vol. 13 (2), 2010
Number 13
Vol.13 (1), 2010
Number 12
Vol.12 (2), 2009
Number 12
Vol.12 (1), 2009
Number 11
Vol.11 (2),2008
Number 11
Vol.11 (1),2008
Number 10
Vol.10 (2), 2007
Number 10
10 (1),2007
Number 9
1&2, 2006
Number 9
3&4, 2006
Number 8
1&2, 2005
Number 8
3&4, 2004
Number 7
1&2, 2004
Number 6
3&4, 2003
Number 6
1&2, 2003
Number 5
3&4, 2002
Number 5
1&2, 2002
Number 4
Vol.3 (4), 2000
Number 4
Vol.2 (4), 1999
Number 4
Vol.1 (4), 1998
Number 4
3&4, 2001
Number 4
1&2, 2001
Number 3
Vol.3 (3), 2000
Number 3
Vol.2 (3), 1999
Number 3
Vol.1 (3), 1998
Number 2
Vol.3(2), 2000
Number 2
Vol.1 (2), 1998
Number 2
Vol.2 (2), 1999
Number 1
Vol.3 (1), 2000
Number 1
Vol.2 (1), 1999
Number 1
Vol.1 (1), 1998

 

 


 About the journal ::: Editorial ::: Subscription ::: Information for authors ::: Contact
 Copyright © Balkan Journal of Medical Genetics 2006